newsfilter
← Latest News
PR Newswire·

BioLineRx to Report 2025 Annual Results on March 23, 2026

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in oncology and...